{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:39:18Z","timestamp":1784547558892,"version":"3.55.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Vice-Chancellor for Research and Technology at Kerman University of Medical Sciences, Kerman, Iran","award":["IR.KMU.REC. 98000777"],"award-info":[{"award-number":["IR.KMU.REC. 98000777"]}]},{"DOI":"10.13039\/100017332","name":"Rafsanjan University of Medical Sciences.","doi-asserted-by":"crossref","award":["Grant No. IR.RUMS.REC. 98193"],"award-info":[{"award-number":["Grant No. IR.RUMS.REC. 98193"]}],"id":[{"id":"10.13039\/100017332","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-79050-6","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T13:02:00Z","timestamp":1731416520000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Human platelet lysate combined with mesenchymal stem cells pretreated with platelet lysate improved cardiac function in rats with myocardial infarction"],"prefix":"10.1038","volume":"14","author":[{"given":"Hamid","family":"Najafipour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzaneh","family":"Rostamzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seedieh","family":"Jafarinejad-Farsangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Bagheri-Hosseinabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Farsinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohmmad Mehdi","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"key":"79050_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/hsc.13156","volume":"30","author":"B \u015eahin","year":"2022","unstructured":"\u015eahin, B. & \u0130lg\u00fcn, G. Risk factors of deaths related to cardiovascular diseases in World Health Organization (WHO) member countries. Health Soc. Care Community 30, 73\u201380 (2022).","journal-title":"Health Soc. Care Community"},{"key":"79050_CR2","doi-asserted-by":"crossref","unstructured":"Ghiroldi, A. et al. Cell-based therapies for cardiac regeneration: A comprehensive review of past and ongoing strategies. Int. J. Mol. Sci. 19 (2018).","DOI":"10.3390\/ijms19103194"},{"key":"79050_CR3","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41569-018-0013-0","volume":"15","author":"P Menasch\u00e9","year":"2018","unstructured":"Menasch\u00e9, P. Cell therapy trials for heart regeneration\u2014Lessons learned and future directions. Nat. Rev. Cardiol. 15, 659\u2013671 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"79050_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/ccd.29710","volume":"99","author":"JM Tyler","year":"2022","unstructured":"Tyler, J. M. et al. Variability in reporting of key outcome predictors in acute myocardial infarction cardiogenic shock trials. Catheter Cardiovasc. Interv. 99, 19\u201326 (2022).","journal-title":"Catheter Cardiovasc. Interv"},{"key":"79050_CR5","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1159\/000492704","volume":"48","author":"P Muller","year":"2018","unstructured":"Muller, P., Lemcke, H. & David, R. Stem cell therapy in heart diseases-cell types, mechanisms and improvement strategies. Cell. Physiol. Biochem. 48, 2607\u20132655 (2018).","journal-title":"Cell. Physiol. Biochem."},{"key":"79050_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/med.21839","volume":"42","author":"H Beli\u00ebn","year":"2022","unstructured":"Beli\u00ebn, H., Evens, L., Hendrikx, M., Bito, V. & Bronckaers, A. Combining stem cells in myocardial infarction: The road to superior repair? Med. Res. Rev. 42, 343\u2013373 (2022).","journal-title":"Med. Res. Rev."},{"key":"79050_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.trsl.2018.07.012","volume":"203","author":"JH Werner","year":"2019","unstructured":"Werner, J. H., Rosenberg, J. H., Um, J. Y., Moulton, M. J. & Agrawal, D. K. Molecular discoveries and treatment strategies by direct reprogramming in cardiac regeneration. Transl Res. 203, 73\u201387 (2019).","journal-title":"Transl Res."},{"key":"79050_CR8","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1253\/circj.CJ-18-0786","volume":"82","author":"K Kobayashi","year":"2018","unstructured":"Kobayashi, K. & Suzuki, K. Mesenchymal stem\/stromal cell-based therapy for heart failure\u2014What is the best source?. Circ. J. 82, 2222\u20132232 (2018).","journal-title":"Circ. J."},{"key":"79050_CR9","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","volume":"41","author":"N Song","year":"2020","unstructured":"Song, N., Scholtemeijer, M. & Shah, K. Mesenchymal stem cell immunomodulation: Mechanisms and therapeutic potential. Trends Pharmacol. Sci. 41, 653\u2013664 (2020).","journal-title":"Trends Pharmacol. Sci."},{"key":"79050_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1139\/cjpp-2023-0202","volume":"102","author":"JK Gill","year":"2024","unstructured":"Gill, J. K., Rehsia, S. K., Verma, E., Sareen, N. & Dhingra, S. Stem cell therapy for cardiac regeneration: Past, present, and future. Can. J. Physiol. Pharmacol. 102, 161\u2013179 (2024).","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"79050_CR11","doi-asserted-by":"crossref","unstructured":"Seow, K. S. & Ling, A. P. K. Mesenchymal stem cells as future treatment for cardiovascular regeneration and its challenges. Ann. Transl Med. 12, (2024).","DOI":"10.21037\/atm-23-1936"},{"key":"79050_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1126\/science.1164680","volume":"324","author":"O Bergmann","year":"2009","unstructured":"Bergmann, O. et al. Evidence for cardiomyocyte renewal in humans. Science 324, 98\u2013102 (2009).","journal-title":"Science"},{"key":"79050_CR13","doi-asserted-by":"crossref","unstructured":"Fisher, S. A., Doree, C., Mathur, A. & Taggart, D. P. & Martin-Rendon, E. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. Cochrane Database Syst. Rev. (2016).","DOI":"10.1002\/14651858.CD007888.pub3"},{"key":"79050_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-020-02489-4","volume":"18","author":"M Guiotto","year":"2020","unstructured":"Guiotto, M., Raffoul, W., Hart, A. M., Riehle, M. O. & Di Summa, P. G. Human platelet lysate to substitute fetal bovine serum in hMSC expansion for translational applications: A systematic review. J. Transl Med. 18, 1\u201314 (2020).","journal-title":"J. Transl Med."},{"key":"79050_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/jama.2013.282909","volume":"311","author":"AW Heldman","year":"2014","unstructured":"Heldman, A. W. et al. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: The TAC-HFT randomized trial. Jama 311, 62\u201373 (2014).","journal-title":"Jama"},{"key":"79050_CR16","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1038\/mt.2014.110","volume":"22","author":"N Tano","year":"2014","unstructured":"Tano, N. et al. Epicardial placement of mesenchymal stromal cell-sheets for the treatment of ischemic cardiomyopathy; in vivo proof-of-concept study. Mol. Ther. 22, 1864\u20131871 (2014).","journal-title":"Mol. Ther."},{"key":"79050_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13287-022-02833-z","volume":"13","author":"YL Zheng","year":"2022","unstructured":"Zheng, Y. L. et al. Stem cell-derived exosomes in the treatment of acute myocardial infarction in preclinical animal models: A meta-analysis of randomized controlled trials. Stem Cell. Res. Ther. 13, 151 (2022).","journal-title":"Stem Cell. Res. Ther."},{"key":"79050_CR18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1161\/CIRCRESAHA.114.300639","volume":"114","author":"S Sahoo","year":"2014","unstructured":"Sahoo, S. & Losordo, D. W. Exosomes and cardiac repair after myocardial infarction. Circ. Res. 114, 333\u2013344 (2014).","journal-title":"Circ. Res."},{"key":"79050_CR19","doi-asserted-by":"publisher","first-page":"H1043","DOI":"10.1152\/ajpheart.00134.2018","volume":"314","author":"TG Walsh","year":"2018","unstructured":"Walsh, T. G. & Poole, A. W. Do platelets promote cardiac recovery after myocardial infarction: Roles beyond occlusive ischemic damage. Am. J. Physiol. Circ. Physiol. 314, H1043\u2013H1048 (2018).","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"79050_CR20","doi-asserted-by":"publisher","first-page":"17172","DOI":"10.1002\/jcp.28496","volume":"234","author":"M Zamani","year":"2019","unstructured":"Zamani, M. et al. Novel therapeutic approaches in utilizing platelet lysate in regenerative medicine: Are we ready for clinical use? J. Cell. Physiol. 234, 17172\u201317186 (2019).","journal-title":"J. Cell. Physiol."},{"key":"79050_CR21","doi-asserted-by":"publisher","first-page":"e32434","DOI":"10.1097\/MD.0000000000032434","volume":"102","author":"Y Cui","year":"2023","unstructured":"Cui, Y. et al. Research trends of platelet-rich plasma therapy on knee osteoarthritis from 2011 to 2021: A review. Med. (Baltim) 102, e32434 (2023).","journal-title":"Med. (Baltim)."},{"key":"79050_CR22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/09537104.2017.1327656","volume":"29","author":"Z Badran","year":"2018","unstructured":"Badran, Z., Abdallah, M. N., Torres, J. & Tamimi, F. Platelet concentrates for bone regeneration: Current evidence and future challenges. Platelets. 29, 105\u2013112 (2018).","journal-title":"Platelets"},{"key":"79050_CR23","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.2147\/OPTH.S391536","volume":"16","author":"JB Nadelmann","year":"2022","unstructured":"Nadelmann, J. B., Bunya, V. Y., Ying, G. S., Hua, P. & Massaro-Giordano, M. Effect of autologous platelet-rich plasma drops in the treatment of ocular surface disease. Clin. Ophthalmol. 16, 4207\u20134213 (2022).","journal-title":"Clin. Ophthalmol."},{"key":"79050_CR24","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1080\/09537104.2018.1430357","volume":"29","author":"J Etulain","year":"2018","unstructured":"Etulain, J. Platelets in wound healing and regenerative medicine. Platelets. 29, 556\u2013568 (2018).","journal-title":"Platelets"},{"key":"79050_CR25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13287-018-0863-8","volume":"9","author":"V Becherucci","year":"2018","unstructured":"Becherucci, V. et al. Human platelet lysate in mesenchymal stromal cell expansion according to a GMP grade protocol: A cell factory experience. Stem Cell. Res. Ther. 9, 124 (2018).","journal-title":"Stem Cell. Res. Ther."},{"key":"79050_CR26","doi-asserted-by":"crossref","unstructured":"Siciliano, C. et al. The potential of GMP-compliant platelet lysate to induce a permissive state for cardiovascular transdifferentiation in human mediastinal adipose tissue-derived mesenchymal stem cells. Biomed Res. Int. (2015).","DOI":"10.1155\/2015\/162439"},{"key":"79050_CR27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00441-012-1360-5","volume":"348","author":"BA Naaijkens","year":"2012","unstructured":"Naaijkens, B. A. et al. Human platelet lysate as a fetal bovine serum substitute improves human adipose-derived stromal cell culture for future cardiac repair applications. Cell. Tissue Res. 348, 119\u2013130 (2012).","journal-title":"Cell. Tissue Res."},{"key":"79050_CR28","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.yjmcc.2008.12.019","volume":"46","author":"S Yabanoglu","year":"2009","unstructured":"Yabanoglu, S. et al. Platelet derived serotonin drives the activation of rat cardiac fibroblasts by 5-HT2A receptors. J. Mol. Cell. Cardiol. 46, 518\u2013525 (2009).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"79050_CR29","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/nature06800","volume":"451","author":"VFM Segers","year":"2008","unstructured":"Segers, V. F. M. & Lee, R. T. Stem-cell therapy for cardiac disease. Nature. 451, 937\u2013942 (2008).","journal-title":"Nature"},{"key":"79050_CR30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s10517-015-2905-x","volume":"159","author":"MS Khubutiya","year":"2015","unstructured":"Khubutiya, M. S. et al. Effect of conditioned medium and bone marrow stem cell lysate on the course of acetaminophen-induced liver failure. Bull. Exp. Biol. Med. 159, 118\u2013123 (2015).","journal-title":"Bull. Exp. Biol. Med."},{"key":"79050_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/2211550110666210908111751","volume":"10","author":"S Malik","year":"2021","unstructured":"Malik, S., Awan, S. J., Hashim, M., Farzand, A. & Nadeem, S. Regeneration potential of bone marrow-derived mesenchymal stromal cells lysate for H2O2 (In-Vitro) injured cells. Curr. Biotechnol. 10, 101\u2013110 (2021).","journal-title":"Curr. Biotechnol."},{"key":"79050_CR32","doi-asserted-by":"crossref","unstructured":"Abkhooie, L. et al. Potential roles of MyomiRs in cardiac development and related diseases. Curr. Cardiol. Rev. 17, (2021).","DOI":"10.2174\/1573403X16999201124201021"},{"key":"79050_CR33","doi-asserted-by":"publisher","first-page":"e0189131","DOI":"10.1371\/journal.pone.0189131","volume":"12","author":"G Yannarelli","year":"2017","unstructured":"Yannarelli, G. et al. OCT4 expression mediates partial cardiomyocyte reprogramming of mesenchymal stromal cells. PLoS One 12, e0189131 (2017).","journal-title":"PLoS One"},{"key":"79050_CR34","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/BF01907132","volume":"85","author":"S Rousscau-Migneron","year":"1990","unstructured":"Rousscau-Migneron, S., Tancrede, G. & Nadeau, A. Lidocaine improves survival rate in diabetic rats submitted to acute left coronary artery ligation. Basic. Res. Cardiol. 85, 404\u2013410 (1990).","journal-title":"Basic. Res. Cardiol."},{"key":"79050_CR35","doi-asserted-by":"publisher","first-page":"113186","DOI":"10.1016\/j.physbeh.2020.113186","volume":"228","author":"Z Behroozi","year":"2021","unstructured":"Behroozi, Z., Ramezani, F., Janzadeh, A., Rahimi, B. & Nasirinezhad, F. Platelet-rich plasma in umbilical cord blood reduces neuropathic pain in spinal cord injury by altering the expression of ATP receptors. Physiol. Behav. 228, 113186 (2021).","journal-title":"Physiol. Behav."},{"key":"79050_CR36","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.biomaterials.2015.10.065","volume":"76","author":"T Burnouf","year":"2016","unstructured":"Burnouf, T., Strunk, D., Koh, M. B. C. & Schallmoser, K. Human platelet lysate: Replacing fetal bovine serum as a gold standard for human cell propagation? Biomaterials 76, 371\u2013387 (2016).","journal-title":"Biomaterials"},{"key":"79050_CR37","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1160\/TH12-11-0875","volume":"110","author":"Y Hayon","year":"2013","unstructured":"Hayon, Y., Dashevsky, O., Shai, E., Varon, D. & Leker, R. R. Platelet lysates stimulate angiogenesis, neurogenesis and neuroprotection after stroke. Thromb. Haemost. 110, 323\u2013330 (2013).","journal-title":"Thromb. Haemost"},{"key":"79050_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-32623-8","volume":"8","author":"R Businaro","year":"2018","unstructured":"Businaro, R. et al. Platelet lysate-derived neuropeptide y influences migration and angiogenesis of human adipose tissue-derived stromal cells. Sci. Rep. 8, 1\u201312 (2018).","journal-title":"Sci. Rep."},{"key":"79050_CR39","doi-asserted-by":"publisher","first-page":"e13312","DOI":"10.1111\/cpr.13312","volume":"55","author":"A Bordin","year":"2022","unstructured":"Bordin, A. et al. Human platelet lysate-derived extracellular vesicles enhance angiogenesis through miR-126. Cell. Prolif. 55, e13312 (2022).","journal-title":"Cell. Prolif."},{"key":"79050_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-018-0773-9","volume":"9","author":"X Guo","year":"2018","unstructured":"Guo, X. et al. Cardiomyocyte differentiation of mesenchymal stem cells from bone marrow: New regulators and its implications. Stem Cell. Res. Ther. 9, 1\u201312 (2018).","journal-title":"Stem Cell. Res. Ther."},{"key":"79050_CR41","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/stem.574","volume":"29","author":"D Shinmura","year":"2011","unstructured":"Shinmura, D. et al. Pretreatment of human mesenchymal stem cells with pioglitazone improved efficiency of cardiomyogenic transdifferentiation and cardiac function. Stem Cells. 29, 357\u2013366 (2011).","journal-title":"Stem Cells"},{"key":"79050_CR42","doi-asserted-by":"publisher","first-page":"11056","DOI":"10.1038\/srep11056","volume":"5","author":"Y Rui","year":"2015","unstructured":"Rui, Y. et al. Epigenetic memory gained by priming with osteogenic induction medium improves osteogenesis and other properties of mesenchymal stem cells. Sci. Rep. 5, 11056 (2015).","journal-title":"Sci. Rep."},{"key":"79050_CR43","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.drudis.2018.05.032","volume":"24","author":"B Li","year":"2019","unstructured":"Li, B., Meng, X. & Zhang, L. microRNAs and cardiac stem cells in heart development and disease. Drug Discov Today 24, 233\u2013240 (2019).","journal-title":"Drug Discov Today"},{"key":"79050_CR44","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1034\/j.1600-0463.2003.1110406.x","volume":"111","author":"K Norrby","year":"2003","unstructured":"Norrby, K. & Ridell, B. Tumour-type\u2010specific capillary endothelial cell stainability in malignant B\u2010cell lymphomas using antibodies against CD31, CD34 and factor VIII. Apmis. 111, 483\u2013489 (2003).","journal-title":"Apmis"},{"key":"79050_CR45","doi-asserted-by":"publisher","first-page":"16813","DOI":"10.1038\/srep16813","volume":"5","author":"D Chen","year":"2015","unstructured":"Chen, D. et al. Crosstalk between SDF-1\/CXCR4 and SDF-1\/CXCR7 in cardiac stem cell migration. Sci. Rep. 5, 16813 (2015).","journal-title":"Sci. Rep."},{"key":"79050_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2019.04.002","volume":"46","author":"P Kumar","year":"2019","unstructured":"Kumar, P. et al. The mesenchymal stem cell secretome: A new paradigm towards cell-free therapeutic mode in regenerative medicine. Cytokine Growth Factor. Rev. 46, 1\u20139 (2019).","journal-title":"Cytokine Growth Factor. Rev."},{"key":"79050_CR47","first-page":"366","volume":"4","author":"Y Xu","year":"2019","unstructured":"Xu, Y., Chen, C., Hellwarth, P. B. & Bao, X. Biomaterials for stem cell engineering and biomanufacturing. Bioact Mater. 4, 366\u2013379 (2019).","journal-title":"Bioact Mater."},{"key":"79050_CR48","first-page":"21","volume":"10","author":"FH Moghadam","year":"2016","unstructured":"Moghadam, F. H., Tayebi, T. & Barzegar, K. Differentiation of rat bone marrow mesenchymal stem cells into adipocytes and cardiomyocytes after treatment with platelet lysate. Int. J. Hematol. Stem Cell. Res. 10, 21 (2016).","journal-title":"Int. J. Hematol. Stem Cell. Res."},{"key":"79050_CR49","first-page":"208","volume":"10","author":"K Baghaei","year":"2017","unstructured":"Baghaei, K. et al. Isolation, differentiation, and characterization of mesenchymal stem cells from human bone marrow. Gastroenterol. Hepatol. bed Bench. 10, 208 (2017).","journal-title":"Gastroenterol. Hepatol. bed Bench"},{"key":"79050_CR50","doi-asserted-by":"publisher","first-page":"10328","DOI":"10.3389\/bjbs.2022.10328","volume":"79","author":"ML Salem","year":"2022","unstructured":"Salem, M. L., El-Bakry, K. A., Moubark, E. H., Sobh, A. & Khalil, S. M. Beneficial modulatory effects of treatment with bone marrow lysate on hematopoietic stem cells and myeloid cells in tumor-bearing mice. Br. J. Biomed. Sci. 79, 10328 (2022).","journal-title":"Br. J. Biomed. Sci."},{"key":"79050_CR51","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.nbt.2014.06.001","volume":"32","author":"DTB Shih","year":"2015","unstructured":"Shih, D. T. B. & Burnouf, T. Preparation, quality criteria, and properties of human blood platelet lysate supplements for ex vivo stem cell expansion. N Biotechnol. 32, 199\u2013211 (2015).","journal-title":"N Biotechnol."},{"key":"79050_CR52","doi-asserted-by":"crossref","unstructured":"Rostamzadeh, F. et al. PEGylated graphene quantum dot improved cardiac function in rats with myocardial infarction: morphological, oxidative stress, and toxicological evidences. Oxid. Med. Cell. Longev. (2021).","DOI":"10.1155\/2021\/8569225"},{"key":"79050_CR53","doi-asserted-by":"publisher","first-page":"H1020","DOI":"10.1152\/ajpheart.01082.2008","volume":"297","author":"L Wang","year":"2009","unstructured":"Wang, L. et al. Adipose-derived stem cells are an effective cell candidate for treatment of heart failure: An MR imaging study of rat hearts. Am. J. Physiol. Circ. Physiol. 297, H1020\u2013H1031 (2009).","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"79050_CR54","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.vascn.2012.05.009","volume":"66","author":"RD Sarazan","year":"2012","unstructured":"Sarazan, R. D., Kroehle, J. P. & Main, B. W. Left ventricular pressure, contractility and dP\/dtmax in nonclinical drug safety assessment studies. J. Pharmacol. Toxicol. Methods 66, 71\u201378 (2012).","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"79050_CR55","unstructured":"Downey, J. M. Measuring infarct size by the tetrazolium method. ISHR Handb. Exp. Lab. Proced. Downey JM, ed. Int. Soc. Hear. Dis. (2000)."},{"key":"79050_CR56","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0009-8981(00)00223-0","volume":"298","author":"JP Bertinchant","year":"2000","unstructured":"Bertinchant, J. P. et al. Comparison of the diagnostic value of cardiac troponin I and T determinations for detecting early myocardial damage and the relationship with histological findings after isoprenaline-induced cardiac injury in rats. Clin. Chim. acta. 298, 13\u201328 (2000).","journal-title":"Clin. Chim. acta"},{"key":"79050_CR57","doi-asserted-by":"publisher","first-page":"33677","DOI":"10.1038\/srep33677","volume":"6","author":"Q Wei","year":"2016","unstructured":"Wei, Q. et al. Ramipril attenuates left ventricular remodeling by regulating the expression of activin A-follistatin in a rat model of heart failure. Sci. Rep. 6, 33677 (2016).","journal-title":"Sci. Rep."},{"key":"79050_CR58","doi-asserted-by":"publisher","first-page":"102127","DOI":"10.1016\/j.legalmed.2022.102127","volume":"59","author":"T Kondo","year":"2022","unstructured":"Kondo, T. et al. Immunohistochemical analysis of CD31 expression in myocardial tissues from autopsies of patients with ischemic heart disease. Leg. Med. 59, 102127 (2022).","journal-title":"Leg. Med."},{"key":"79050_CR59","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1089\/ten.tea.2015.0461","volume":"22","author":"TH Kim","year":"2016","unstructured":"Kim, T. H., Kim, S. H., Leong, K. W. & Jung, Y. Nanografted Substrata and triculture of human pericytes, fibroblasts, and endothelial cells for studying the effects on Angiogenesis. Tissue Eng. Part. A 22, 698\u2013706 (2016).","journal-title":"Tissue Eng. Part. A"},{"key":"79050_CR60","first-page":"3527","volume":"19","author":"Y Hu","year":"2019","unstructured":"Hu, Y. et al. MicroRNA-1 downregulation induced by carvedilol protects cardiomyocytes against apoptosis by targeting heat shock protein 60. Mol. Med. Rep. 19, 3527\u20133536 (2019).","journal-title":"Mol. Med. Rep."},{"key":"79050_CR61","doi-asserted-by":"publisher","first-page":"12276","DOI":"10.1038\/srep12276","volume":"5","author":"Z Xu","year":"2015","unstructured":"Xu, Z. et al. MiR-135b-5p and MiR-499a-3p promote cell proliferation and migration in atherosclerosis by directly targeting MEF2C. Sci. Rep. 5, 12276 (2015).","journal-title":"Sci. Rep."},{"key":"79050_CR62","first-page":"6707","volume":"24","author":"X Wang","year":"2018","unstructured":"Wang, X., Yang, C., Liu, X. & Yang, P. Ghrelin alleviates angiotensin II-induced H9c2 apoptosis: Impact of the miR-208 family. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 24, 6707 (2018).","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"79050_CR63","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.3390\/cells10112819","volume":"10","author":"N Ebrahim","year":"2021","unstructured":"Ebrahim, N. et al. Functional recellularization of acellular rat liver scaffold by induced pluripotent stem cells: Molecular evidence for wnt\/b-catenin upregulation. Cells. 10, 2819 (2021).","journal-title":"Cells"},{"key":"79050_CR64","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1113\/JP275339","volume":"596","author":"Y Asif","year":"2018","unstructured":"Asif, Y. et al. Sustained cardiac programming by short-term juvenile exercise training in male rats. J. Physiol. 596, 163\u2013180 (2018).","journal-title":"J. Physiol."},{"key":"79050_CR65","doi-asserted-by":"crossref","unstructured":"Alzahrani, F. A. et al. Potential effect of exosomes derived from cancer stem cells and MSCs on progression of DEN-induced HCC in rats. Stem Cells Int. 8058979 (2018).","DOI":"10.1155\/2018\/8058979"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79050-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79050-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79050-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T00:05:11Z","timestamp":1731801911000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79050-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,12]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["79050"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-79050-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,12]]},"assertion":[{"value":"10 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27701"}}